NCT02182076View on ClinicalTrials.gov

Pharmacokinetics/Bioavailability of BIBF 1120 Administered to Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

November 30, 2005

Conditions
Healthy
Interventions
DRUG

BIBF 1120

150 mg of BIBF 1120 ES soft gelatine capsules

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY